Avtor/Urednik		Dietel, Manfred
Naslov		Serous borderline tumors of the ovary - a 2003 update
Tip		članek
Vir		In: Vizjak A, Ferluga D, Bussolati G, editors. Update in pathology. Proceedings of the 19th European congress of pathology: nephropathology pre-congress meeting advances in nephrology, pulmonary pathology pre-congress meeting; 2003 Sep 6-11; Ljubljana. Ljubljana: Faculty of medicine,
Leto izdaje		2003
Obseg		str. 132-6
Jezik		eng
Abstrakt		The new WHO series on Pathology and Genetics of Tumours of the Breast and Female Genital Organs (to be published in autumn 2003) defined to name the group of epithelial ovarian tumors with a dignity between benign and malignant exclusively as Borderline Tumors of the Ovary (BOT) and to skip the term "... of low malignant potential". The group of borderline ovarian tumors is heterogeneous. 80 to 90% shows a very favorable prognosis while 10-20% exhibit a worse clinical course with peritoneal implants and very rarely death from the tumor within 10 years. The morphological criteria and supporting methods for recognizing unfavorable BOT and for distinguishing them from highly differentiated ovarian carcinomas are summarized. The prognostic importance of peritoneal implants is described. The concept of micropapillary serous carcinomas (MPSC) and its implications on the diagnostic work of pathologists will be discussed. The presented data focus on serous tumors since this is by far the most common variant.
Deskriptorji		OVARIAN NEOPLASMS CARCINOMA, PAPILLARY IMMUNOPHENOTYPING